Phaseline

Targets › GABBR2

GABBR2 (Gamma-aminobutyric acid type B receptor subunit 2): drug programs, companies and trials

6 programs from 6 companies in 7 trials: 4 Phase 2, 2 Phase 3, 1 Phase 4; Psychiatry, Other, Neurology; next expected readout Dec 2026.

Component of a heterodimeric G protein-coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins. (UniProt, O75899)

Open in Phaseline: the race on GABBR2, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Mayo ClinicLow Sodium Oxybate
GABA-B receptor agonist; sodium and salt-balanced formulation of sodium oxybate
GABBR1, GABBR2Phase 4Idiopathic HypersomniaJan 2027
Hospital General Universitario Gregorio MarañonArbaclofen
GABA-B receptor agonist
GABBR1, GABBR2Phase 3Autism Spectrum DisordersDec 2026
Tanta UniversityBaclofen
GABA-B receptor agonist
GABBR1, GABBR2Phase 3Post Operative Pain–
Hospices Civils de LyonBaclofen
GABA-B receptor agonist
GABBR1, GABBR2Phase 2Benzodiazepine DependenceOct 2028
Adnan Imtiaj RahulBaclofen
GABA-B receptor agonist
GABBR1, GABBR2Phase 2GERD - PPI Non-responders–
Children's Hospital Medical Center, CincinnatiBaclofen
GABA-B receptor agonist
GABBR1, GABBR2Phase 2Fragile X Syndrome–

Conditions

Benzodiazepine Dependence (2) Idiopathic Hypersomnia (1) Autism Spectrum Disorders (1) GERD - PPI Non-responders (1) Post Operative Pain (1) Fragile X Syndrome (1)

Modalities

small molecule (6)

Companies

Mayo Clinic (1) Hospital General Universitario Gregorio Marañon (1) Adnan Imtiaj Rahul (1) Hospices Civils de Lyon (1) Tanta University (1) Children's Hospital Medical Center, Cincinnati (1)

Related targets

GABBR1 (6)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.